5.15 - Targeting and Triggered Release Using Lipid-Based Supramolecular Assemblies as Medicinal Nanocarriers
References (0)
Cited by (17)
Liposome triggered content release through molecular recognition of inositol trisphosphate
2022, Chemical CommunicationsStrategies for altering lipid self-assembly to trigger liposome cargo release
2020, Chemistry and Physics of LipidsCitation Excerpt :However, in addition to drug delivery, liposomes are beneficial for applications including actions as sensors (Barba-Bon et al., 2019; Liu and Boyd, 2013; Mazur et al., 2017) and for enhancing catalysis by entrapping reagents (Cuccovia and Chaimovich, 2018; Song et al., 2006). The advancement of triggered release strategies has focused on the development of liposomes that respond to stimuli that are relevant to disease (Alam et al., 2017). While we won’t categorize prior work based on this aspect in this review, we will point out that these approaches have typically fallen into two categories.
Reactive Oxygen Species-Responsive Liposomes via Boronate-Caged Phosphatidylethanolamine
2020, Bioconjugate ChemistryCell mimetic liposomal nanocarriers for tailored delivery of vascular therapeutics
2019, Chemistry and Physics of LipidsCitation Excerpt :Liposomal delivery systems (LDSs) have remained the premier theranostic nanotechnology since their emergence more than 30 years ago (Alam et al., 2017; Barenholz, 2012; Pattni et al., 2015).
Activity-Based Nitric Oxide-Responsive Porphyrin for Site-Selective and Nascent Cancer Ablation
2024, ACS Applied Materials and InterfacesQuercetin-loaded Liposomes Effectively Induced Apoptosis and Decreased the Epidermal Growth Factor Receptor Expression in Colorectal Cancer Cells: An In Vitro Study
2023, Iranian Journal of Medical Sciences